Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | HMGCR | P04035 | 9/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11514172 | 0.88 | CTSA (0.43) | CTSAACHEALDH1A1KDM4EPOLB | |
| SCHEMBL11515008 | 0.88 | CTSA (0.43) | CTSAACHEALDH1A1KDM4EPOLB | |
| SCHEMBL11516051 | 0.86 | CTSA (0.42) | CTSAACHEALDH1A1KDM4EPOLB | |
| SCHEMBL11514169 | 0.86 | CTSA (0.42) | CTSAACHEALDH1A1KDM4EPOLB | |
| SCHEMBL7739962 | 0.86 | CTSA (0.42) | CTSAACHEALDH1A1KDM4EPOLB | |
| SCHEMBL4736507 | 0.86 | CTSA (0.42) | CTSAACHEALDH1A1KDM4EPOLB | |
| SCHEMBL6618745 | 0.84 | CTSA (0.40) | CTSAACHEALDH1A1KDM4EPOLB | |
| SCHEMBL525808 | 0.84 | CTSA (0.40) | CTSAACHEALDH1A1KDM4EPOLB | |
| SCHEMBL525398 | 0.84 | CTSA (0.40) | CTSAACHEALDH1A1KDM4EPOLB | |
| SCHEMBL2322178 | 0.83 | HMGCR (0.39) | CTSAACHEALDH1A1HMGCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7256308-B2 | Carbonylating methanol with an iridium carbonylation catalyst, methyl iodide, methyl acetate, water, acetic acid, a promoter of ruthenium, rhenium or osmium, and a bis-phosphonate compound | BP CHEMICALS LIMITED (GB) | 2007-08-14 | — | — | US | claimed |
| US-20050131251-A1 | Process for the production of acetic acid | BP CHEMICALS LIMITED (GB) | 2005-06-16 | — | — | US | claimed |
| US-4141967-A | ANHYDROUS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 1979-02-27 | — | — | US | claimed |
| EP-3261155-B1 | CONDUCTIVE PASTE AND MIXTURE PASTE FOR LITHIUM ION BATTERY POSITIVE ELECTRODE | KANSAI PAINT CO LTD (JP) | 2023-11-01 | — | — | EP | disclosed |
| US-10468683-B2 | Conductive paste and mixture paste for lithium ion battery positive electrode | KANSAI PAINT CO., LTD. (JP) | 2019-11-05 | — | — | US | disclosed |
| US-10103401-B2 | Polymer electrolyte composition and polymer electrolyte membrane, polymer electrolyte membrane with catalyst layer, membrane electrode assembly, and polymer electrolyte fuel cell each using the same | TORAY INDUSTRIES, INC. (JP) | 2018-10-16 | — | — | US | disclosed |
| EP-3131145-B1 | POLYMER ELECTROLYTE COMPOSITION AND POLYMER ELECTROLYTE MEMBRANE, MEMBRANE-ELECTROLYTE ASSEMBLY, AND SOLID POLYMER FUEL CELL USING SAME | TORAY INDUSTRIES (JP) | 2018-09-05 | — | — | EP | disclosed |
| EP-2598509-B1 | METHOD OF THE SYNTHESIS OF DIETHYL OR DIISOPROPYL HALOALKYLPHOSPHONATES AND DIETHYL OR DIISOPROPYL HALOALKYLOXYALKYLPHOSPHONATES | ÚSTAV ORGANICKÉ CHEMIE A BIOCHEMIE AKADEMIE VED CESKE REPUBLIKY V V I (CZ) | 2018-02-07 | — | — | EP | disclosed |
| US-20170373319-A1 | CONDUCTIVE PASTE AND MIXTURE PASTE FOR LITHIUM ION BATTERY POSITIVE ELECTRODE | KANSAI PAINT CO., LTD. (JP) | 2017-12-28 | — | — | US | disclosed |
| EP-3261155-A1 | CONDUCTIVE PASTE AND MIXTURE PASTE FOR LITHIUM ION BATTERY POSITIVE ELECTRODE | Kansai Paint Co., Ltd (JP) | 2017-12-27 | — | — | EP | disclosed |
| US-20170125832-A1 | POLYMER ELECTROLYTE COMPOSITION AND POLYMER ELECTROLYTE MEMBRANE, POLYMER ELECTROLYTE MEMBRANE WITH CATALYST LAYER, MEMBRANE ELECTRODE ASSEMBLY, AND POLYMER ELECTROLYTE FUEL CELL EACH USING THE SAME | TORAY INDUSTRIES, INC. (JP) | 2017-05-04 | — | — | US | disclosed |
| EP-3131145-A1 | POLYMER ELECTROLYTE COMPOSITION AND POLYMER ELECTROLYTE MEMBRANE, MEMBRANE-ELECTROLYTE ASSEMBLY, AND SOLID POLYMER FUEL CELL USING SAME | Toray Industries, Inc. (JP) | 2017-02-15 | — | — | EP | disclosed |
| EP-2598509-A1 | METHOD OF THE SYNTHESIS OF DIALKYL HALOALKYLPHOSPHONATES AND DIALKYL HALOALKYLOXYALKYLPHOSPHONATES | Ustav Organicke Chemie a Biochemie Akademie Ved Ceske Republiky, V.V.I. (CZ) | 2013-06-05 | — | — | EP | disclosed |
| WO-2012013168-A1 | METHOD OF THE SYNTHESIS OF DIALKYL HALOALKYLPHOSPHONATES AND DIALKYL HALOALKYLOXYALKYLPHOSPHONATES | ÚSTAV ORGANICKÉ CHEMIE A BIOCHEMIE AKADEMIE VĚD ČESKÉ REPUBLIKY, v.v.i. (CZ) | 2012-02-02 | — | — | WO | disclosed |
| US-7256308-B2 | Carbonylating methanol with an iridium carbonylation catalyst, methyl iodide, methyl acetate, water, acetic acid, a promoter of ruthenium, rhenium or osmium, and a bis-phosphonate compound | BP CHEMICALS LIMITED (GB) | 2007-08-14 | — | — | US | disclosed |
| US-20050131251-A1 | Process for the production of acetic acid | BP CHEMICALS LIMITED (GB) | 2005-06-16 | — | — | US | disclosed |
| US-6310093-B1 | ADMINISTERING, IN AMOUNT EFFECTIVE TO REDUCE DAMAGE TO NEURONAL CELLS, COMPOUND WHICH SELECTIVELY INHIBITS EXTRACELLULAR GLUTAMINASE RELATIVE TO GLUTAMINASE PRESENT IN INTACT CELLS AND IS IMPERMEABLE TO INTACT CELL MEMBRANES | ELAN PHARMACEUTICALS, INC. | 2001-10-30 | — | — | US | disclosed |
| WO-1999009825-A1 | METHOD OF PREVENTING NEURONAL DEATH | ELAN PHARMACEUTICALS, INC. (US) | 1999-03-04 | — | — | WO | disclosed |
| US-4141967-A | ANHYDROUS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 1979-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050131251-A1 | Process for the production of acetic acid | ME1, INO80C, INO80 | CTSA 4223/4885ACHE 623/4885ALDH1A1 219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.